Thursday, November 12, 2020

Vaccine - good for some

 Albert Bourla, Pfizer’s chief executive sold shares in the company worth $5.6m (£4.2m) on the day the drug-maker announced its Covid-19 vaccine.

Bourla sold 132,508 shares at $41.94 a share, equivalent to 62% of his shareholding in Pfizer. This is close to the $41.99 peak the share price hit on Monday.

No comments: